Alternative splicing in disease and therapy
The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Abstract
Alternative splicing is the major source of proteome diversity in humans and thus is highly relevant to disease and therapy. For example, recent work suggests that the long-sought-after target of the analgesic acetaminophen is a neural-specific, alternatively spliced isoform of cyclooxygenase 1 (COX-1). Several important diseases, such as cystic fibrosis, have been linked with mutations or variations in either cis-acting elements or trans-acting factors that lead to aberrant splicing and abnormal protein production. Correction of erroneous splicing is thus an important goal of molecular therapies. Recent experiments have used modified oligonucleotides to inhibit cryptic exons or to activate exons weakened by mutations, suggesting that these reagents could eventually lead to effective therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the occurrence of elastosis assumes an increase in elastic material in the photoaged skin, as observed in other studies [22, 56].”
From Elastin structure and its involvement in skin photoageing (2017) · cites this paper as [56]
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Listening to silence and understanding nonsense: exonic mutations that affect splicing
Cartegni, L., Chew, S. L., & Krainer, A. R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg775 · Cited by 2,209
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Human Gene Mutation Database (HGMD®): 2003 update: HGMD 2003 UPDATE
Stenson, P. D., Ball, E. V., Mort, M., Phillips, A. D., Shiel, J. A., Thomas, N. S. T., Abeysinghe, S., Krawczak, M., & Cooper, D. N. (2003) · Human Mutation · doi:10.1002/humu.10212 · Cited by 1,829
Zamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792
Cited by
Analyses of pig genomes provide insight into porcine demography and evolution
Groenen, M. A. M., Archibald, A. L., Uenishi, H., Tuggle, C. K., Takeuchi, Y., Rothschild, M. F., Rogel-Gaillard, C., Park, C., Milan, D., Megens, H.-J., et al. (2012) · Nature · doi:10.1038/nature11622 · Cited by 1,385
Gene co-expression analysis for functional classification and gene–disease predictions
van Dam, S., Võsa, U., van der Graaf, A., Franke, L., & de Magalhães, J. P. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbw139 · Cited by 995
Alternative splicing and evolution: diversification, exon definition and function
Keren, H., Lev-Maor, G., & Ast, G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2776 · Cited by 1,082
“Due to these advances, the regulation of AS is being widely used in gene therapy, revealing new therapeutic target”
BackgroundRNA splicing is a primary link between genetic variation and disease
Li, Y. I., van de Geijn, B., Raj, A., Knowles, D. A., Petti, A. A., Golan, D., Gilad, Y., & Pritchard, J. K. (2016) · Science · doi:10.1126/science.aad9417 · Cited by 660
for the Multiple Sclerosis Genetics Group, Gregory, S. G., Schmidt, S., Seth, P., Oksenberg, J. R., Hart, J., Prokop, A., Caillier, S. J., Ban, M., Goris, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2103 · Cited by 657
Aberrant and Alternative Splicing in Cancer
Venables, J. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1910 · Cited by 634
Scaffidi, P., & Misteli, T. (2005) · Nature Medicine · doi:10.1038/nm1204 · Cited by 553
Thousands of exon skipping events differentiate among splicing patterns in sixteen human tissues
Florea, L., Song, L., & Salzberg, S. L. (2013) · F1000Research · doi:10.12688/f1000research.2-188.v2 · Cited by 416
Thousands of exon skipping events differentiate among splicing patterns in sixteen human tissues
Florea, L., Song, L., & Salzberg, S. L. (2013) · F1000Research · doi:10.12688/f1000research.2-188.v1 · Cited by 526
Splicing in action: assessing disease causing sequence changes
Baralle, D., & Baralle, M. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.029538 · Cited by 508
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes
Sveen, A., Kilpinen, S., Ruusulehto, A., Lothe, R. A., & Skotheim, R. I. (2016) · Oncogene · doi:10.1038/onc.2015.318 · Cited by 470
TDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail
Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S., Ayala, Y. M., & Baralle, F. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505557200 · Cited by 460
Singh, N. K., Singh, N. N., Androphy, E. J., & Singh, R. N. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1333-1346.2006 · Cited by 454
Influence of RNA Secondary Structure on the Pre-mRNA Splicing Process
Buratti, E., & Baralle, F. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10505-10514.2004 · Cited by 427
hnRNP Proteins and Splicing Control
Martinez-Contreras, R., Cloutier, P., Shkreta, L., Fisette, J.-F., Revil, T., & Chabot, B. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-77374-2_8 · Cited by 398
Krawczak, M., Thomas, N. S. T., Hundrieser, B., Mort, M., Wittig, M., Hampe, J., & Cooper, D. N. (2007) · Human Mutation · doi:10.1002/humu.20400 · Cited by 374
Natural and engineered nucleic acids as tools to explore biology
Breaker, R. R. (2004) · Nature · doi:10.1038/nature03195 · Cited by 362
Onozato, R., Kosaka, T., Kuwano, H., Sekido, Y., Yatabe, Y., & Mitsudomi, T. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181913e0e · Cited by 327
Lessons from non-canonical splicing
Sibley, C. R., Blazquez, L., & Ule, J. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.46 · Cited by 316
Antibody-based Proteomics for Human Tissue Profiling
Uhlen, M., & Ponten, F. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r500009-mcp200 · Cited by 303
Alternative splicing: an emerging topic in molecular and clinical oncology
Pajares, M. J., Ezponda, T., Catena, R., Calvo, A., Pio, R., & Montuenga, L. M. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70104-3 · Cited by 267
Learning the Sequence Determinants of Alternative Splicing from Millions of Random Sequences
Rosenberg, A. B., Patwardhan, R. P., Shendure, J., & Seelig, G. (2015) · Cell · doi:10.1016/j.cell.2015.09.054 · Cited by 268
Massone, S., Vassallo, I., Fiorino, G., Castelnuovo, M., Barbieri, F., Borghi, R., Tabaton, M., Robello, M., Gatta, E., Russo, C., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.019 · Cited by 240
Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution
Pagani, F., Raponi, M., & Baralle, F. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502288102 · Cited by 246
Pathophysiological Roles of ASK1-MAP Kinase Signaling Pathways
Nagai, H., Noguchi, T., Takeda, K., & Ichijo, H. (2007) · BMB Reports · doi:10.5483/bmbrep.2007.40.1.001 · Cited by 241
Engineering RNA sequence specificity of Pumilio repeats
Cheong, C.-G., & Hall, T. M. T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606294103 · Cited by 230
Genome-Wide Association between Branch Point Properties and Alternative Splicing
Corvelo, A., Hallegger, M., Smith, C. W. J., & Eyras, E. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001016 · Cited by 231
Defective splicing, disease and therapy: searching for master checkpoints in exon definition
Buratti, E. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl498 · Cited by 213
Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs
Yuan, Y., Compton, S. A., Sobczak, K., Stenberg, M. G., Thornton, C. A., Griffith, J. D., & Swanson, M. S. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm601 · Cited by 212
Mochel, F., Knight, M. A., Tong, W.-H., Hernandez, D., Ayyad, K., Taivassalo, T., Andersen, P. M., Singleton, A., Rouault, T. A., Fischbeck, K. H., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.012 · Cited by 210
Das, S., Miller, M., Beppu, A. K., Mueller, J., McGeough, M. D., Vuong, C., Karta, M. R., Rosenthal, P., Chouiali, F., Doherty, T. A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610433113 · Cited by 204
Alterations of pre‐mRNA splicing in cancer
Kalnin̨a, Z., Zayakin, P., Silin̨a, K., & Linē, A. (2005) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20156 · Cited by 196
Elastin structure and its involvement in skin photoageing
Weihermann, A. C., Lorencini, M., Brohem, C. A., & de Carvalho, C. M. (2017) · International Journal of Cosmetic Science · doi:10.1111/ics.12372 · Cited by 195
Alternative splicing in neurodegenerative disease and the promise of RNA therapies
Nikom, D., & Zheng, S. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00717-6 · Cited by 190
Sickmier, E. A., Frato, K. E., Shen, H., Paranawithana, S. R., Green, M. R., & Kielkopf, C. L. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.025 · Cited by 187
Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity
Hiller, M., Huse, K., Szafranski, K., Jahn, N., Hampe, J., Schreiber, S., Backofen, R., & Platzer, M. (2004) · Nature Genetics · doi:10.1038/ng1469 · Cited by 184
Tag-based approaches for transcriptome research and genome annotation
Harbers, M., & Carninci, P. (2005) · Nature Methods · doi:10.1038/nmeth768 · Cited by 184
Alternative splicing isoforms in health and disease
Kim, H. K., Pham, M. H. C., Ko, K. S., Rhee, B. D., & Han, J. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2136-x · Cited by 167
Genetic therapies for RNA mis-splicing diseases
Hammond, S. M., & Wood, M. J. A. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.02.004 · Cited by 165
Insights into the connection between cancer and alternative splicing
Kim, E., Goren, A., & Ast, G. (2008) · Trends in Genetics · doi:10.1016/j.tig.2007.10.001 · Cited by 164
Xing, Y. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl396 · Cited by 161
SON Controls Cell-Cycle Progression by Coordinated Regulation of RNA Splicing
Ahn, E.-Y., DeKelver, R. C., Lo, M.-C., Nguyen, T. A., Matsuura, S., Boyapati, A., Pandit, S., Fu, X.-D., & Zhang, D.-E. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.014 · Cited by 162
Discovery and Analysis of Evolutionarily Conserved Intronic Splicing Regulatory Elements
Yeo, G. W., Nostrand, E. L. V., & Liang, T. Y. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030085 · Cited by 160
Alternative splicing: Human disease and quantitative analysis from high-throughput sequencing
Jiang, W., & Chen, L. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.12.009 · Cited by 184
Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase
Yuan, J., Ma, Y., Huang, T., Chen, Y., Peng, Y., Li, B., Li, J., Zhang, Y., Song, B., Sun, X., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.09.002 · Cited by 151
AI applications in functional genomics
Caudai, C., Galizia, A., Geraci, F., Le Pera, L., Morea, V., Salerno, E., Via, A., & Colombo, T. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.10.009 · Cited by 137
Gooding, C., Clark, F., Wollerton, M. C., Grellscheid, S.-N., Groom, H., & Smith, C. W. (2006) · Genome Biology · doi:10.1186/gb-2006-7-1-r1 · Cited by 144
Multiple Alternative Splicing Markers for Ovarian Cancer
Klinck, R., Bramard, A., Inkel, L., Dufresne-Martin, G., Gervais-Bird, J., Madden, R., Paquet, E. R., Koh, C., Venables, J. P., Prinos, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2580 · Cited by 152
Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos
Morcos, P. A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.172 · Cited by 144
Chen, H.-H., Wang, Y.-C., & Fann, M.-J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2736-2745.2006 · Cited by 147
Endosome trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates
Abes, S., Williams, D., Prévôt, P., Thierry, A. R., Gait, M. J., & Lebleu, B. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.026 · Cited by 149
The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing
Warf, M. B., Diegel, J. V., von Hippel, P. H., & Berglund, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900342106 · Cited by 143
Kalb, R., Neveling, K., Hoehn, H., Schneider, H., Linka, Y., Batish, S. D., Hunt, C., Berwick, M., Callén, E., Surrallés, J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/517616 · Cited by 144
Malouf, G. G., Su, X., Yao, H., Gao, J., Xiong, L., He, Q., Compérat, É., Couturier, J., Molinié, V., Escudier, B. J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3036 · Cited by 146
The role of KLF6 and its splice variants in cancer therapy
DiFeo, A. V., Martignetti, J. A., & Narla, G. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.11.001 · Cited by 141
Alternative splicing: the pledge, the turn, and the prestige
Gallego-Paez, L. M., Bordone, M. C., Leote, A. C., Saraiva-Agostinho, N., Ascensão-Ferreira, M., & Barbosa‐Morais, N. L. (2017) · Human Genetics · doi:10.1007/s00439-017-1790-y · Cited by 164
Younis, I., Berg, M. G., Kaida, D., Dittmar, K. A., Wang, C., & Dreyfuss, G. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01301-09 · Cited by 147
siRNA, miRNA, and shRNA: in vivo Applications
Pushparaj, P. N., Aarthi, J. J., Manikandan, J., & Srinivasan, D. K. (2008) · Journal of Dental Research · doi:10.1177/154405910808701109 · Cited by 152
Tetracycline aptamer-controlled regulation of pre-mRNA splicing in yeast
Weigand, J. E., & Suess, B. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm425 · Cited by 127
Human transcriptome array for high-throughput clinical studies
Xu, W., Seok, J., Mindrinos, M. N., Schweitzer, A. C., Jiang, H., Wilhelmy, J., Clark, T. A., Kapur, K., Xing, Y., Faham, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019753108 · Cited by 124
Soret, J., Bakkour, N., Maire, S., Durand, S., Zekri, L., Gabut, M., Fic, W., Divita, G., Rivalle, C., Dauzonne, D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409829102 · Cited by 124
Exon identity crisis: disease-causing mutations that disrupt the splicing code
Sterne-Weiler, T., & Sanford, J. R. (2014) · Genome Biology · doi:10.1186/gb4150 · Cited by 118
Alternative splicing and protein structure evolution
Birzele, F., Csaba, G., & Zimmer, R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1054 · Cited by 134
Oltean, S., Sorg, B. S., Albrecht, T. R., Bonano, V. I., Brazas, R. M., Dewhirst, M. W., & García-Blanco, M. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603090103 · Cited by 127
Du, L., Pollard, J. M., & Gatti, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608616104 · Cited by 114
Integrative analysis revealed the molecular mechanism underlying RBM10‐mediated splicing regulation
Wang, Y., Gogol‐Döring, A., Hu, H., Fröhler, S., Ma, Y., Jens, M., Maaskola, J., Murakawa, Y., Quedenau, C., Landthaler, M., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302663 · Cited by 129
RNA splicing in human disease and in the clinic
Baralle, D., & Buratti, E. (2017) · Clinical Science · doi:10.1042/cs20160211 · Cited by 119
Opportunities and methods for studying alternative splicing in cancer with RNA-Seq
Feng, H., Qin, Z., & Zhang, X. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.010 · Cited by 121
Alternative Splicing as a Target for Cancer Treatment
Martínez-Montiel, N., Rosas-Murrieta, N. H., Anaya-Ruíz, M., Monjaraz-Guzmán, E., & Martínez-Contreras, R. D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020545 · Cited by 122
Polymer Nanoparticle-Mediated Delivery of MicroRNA Inhibition and Alternative Splicing
Cheng, C. J., & Saltzman, W. M. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300081s · Cited by 98
Modulating the Expression of Disease Genes with RNA-Based Therapy
Wood, M., Yin, H., & McClorey, G. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030109 · Cited by 98
The molecular elements that underlie developmental evolution
Alonso, C. R., & Wilkins, A. S. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1676 · Cited by 96
Alternative splicing as a biomarker and potential target for drug discovery
Le, K.-Q., Prabhakar, B. S., Hong, W.-J., & Li, L.-C. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.43 · Cited by 98
Review: Alternative Splicing (AS) of Genes As An Approach for Generating Protein Complexity
Roy, B., Haupt, L. M., & Griffiths, L. R. (2013) · Current Genomics · doi:10.2174/1389202911314030004 · Cited by 111
Trans-Splicing-Mediated Improvement in a Severe Mouse Model of Spinal Muscular Atrophy
Coady, T. H., & Lorson, C. L. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4489-09.2010 · Cited by 95
Tang, H., Beer, L. A., Tanyi, J. L., Zhang, R., Liu, Q., & Speicher, D. W. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.06.016 · Cited by 99
ZHENG, C. L., Fu, X., & Gribskov, M. (2005) · RNA · doi:10.1261/rna.2660805 · Cited by 93
Structure and Function of the Pre-mRNA Splicing Machine
Sperling, J. M., Azubel, M., & Sperling, R. (2008) · Structure · doi:10.1016/j.str.2008.08.011 · Cited by 88
Revil, T., Pelletier, J., Toutant, J., Cloutier, A., & Chabot, B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.019711 · Cited by 91
Using bioinformatics to predict the functional impact of SNVs
Cline, M. S., & Karchin, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btq695 · Cited by 90
A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms
Donev, R., Newall, A. E. T., Thome, J., & Sheer, D. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001971 · Cited by 92
Pre-messenger RNA processing and its regulation: a genomic perspective
Soller, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5391-x · Cited by 103
Extensive relationship between antisense transcription and alternative splicing in the human genome
Morrissy, A. S., Griffith, M., & Marra, M. A. (2011) · Genome Research · doi:10.1101/gr.113431.110 · Cited by 88
A survey of alternative transcripts of human tissue kallikrein genes
Kurlender, L., Borgoño, C. A., Michael, I. P., Obiezu, C. V., Elliott, M. B., Yousef, G. M., & Diamandis, E. P. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.02.001 · Cited by 100
Development of a Single Vector System that Enhances Trans-Splicing of SMN2 Transcripts
Coady, T. H., Baughan, T. D., Shababi, M., Passini, M. A., & Lorson, C. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003468 · Cited by 85
Restoration of SMN Function: Delivery of a Trans-splicing RNA Re-directs SMN2 Pre-mRNA Splicing
Coady, T. H., Shababi, M., Tullis, G. E., & Lorson, C. L. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300222 · Cited by 90
Identification of RNA bound to the TDP-43 ribonucleoprotein complex in the adult mouse brain
Narayanan, R. K., Mangelsdorf, M., Panwar, A., Butler, T. J., Noakes, P. G., & Wallace, R. H. (2012) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2012.734520 · Cited by 89
Adamson, S. I., Zhan, L., & Graveley, B. R. (2018) · Genome Biology · doi:10.1186/s13059-018-1437-x · Cited by 89
Splice-site pairing is an intrinsically high fidelity process
Fox-Walsh, K. L., & Hertel, K. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813128106 · Cited by 82
A Global View of Cancer-Specific Transcript Variants by Subtractive Transcriptome-Wide Analysis
He, C., Zhou, F., Zuo, Z., Cheng, H., & Zhou, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004732 · Cited by 92
Alternative splicing in multiple sclerosis and other autoimmune diseases
Evsyukova, I. Y., Somarelli, J. A., Gregory, S. G., & García-Blanco, M. A. (2010) · RNA Biology · doi:10.4161/rna.7.4.12301 · Cited by 95
Flexible analysis of RNA-seq data using mixed effects models
Turro, E., Astle, W. J., & Tavaré, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt624 · Cited by 84
Potential of Peptide Nucleic Acids in Future Therapeutic Applications
Montazersaheb, S., Hejazi, M. S., & Charoudeh, H. N. (2018) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2018.064 · Cited by 89
The splicing machinery is a genetic modifier of disease severity
Nissim‐Rafinia, M., & Kerem, B. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.07.005 · Cited by 81
eQTL Mapping Using RNA-seq Data
Sun, W., & Hu, Y. (2013) · Statistics in Biosciences · doi:10.1007/s12561-012-9068-3 · Cited by 83
Marden, J. H. (2006) · Heredity · doi:10.1038/sj.hdy.6800904 · Cited by 79
Zhang, Y., Lu, Y., Yuan, B., Castranova, V., Shi, X., Stauffer, J. L., Demers, L. M., & Chen, F. (2005) · Oncogene · doi:10.1038/sj.onc.1208668 · Cited by 81
Du, L., Kayalı, R., Bertoni, C., Fike, F. M., Hu, H., Iversen, P. L., & Gatti, R. A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr217 · Cited by 74
Einstein, R., Jordan, H., Zhou, W., Brenner, M., Moses, E. G., & Liggett, S. B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801319105 · Cited by 74
Stimulating Full-Length SMN2 Expression by Delivering Bifunctional RNAs via a Viral Vector
Baughan, T., Shababi, M., Coady, T. H., Dickson, A. M., Tullis, G. E., & Lorson, C. L. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.012 · Cited by 73
Metadata
- Authors
- Garcia-Blanco, M. A., Baraniak, A. P., & Lasda, E. L.
- Affiliations
- Duke University (US)
- ORCID
- Lasda, Erika L
- Venue
- Nature Biotechnology
- Published
- 2004-05
- Volume
- 22
- Issue
- 5
- Pages
- 535-546
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2070564797
- Cited by
- 527
- References
- 192
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 9 · 2023: 16 · 2022: 13 · 2021: 10 · 2020: 14 · 2019: 15 · 2018: 18 · 2017: 19 · 2016: 16 · 2015: 21 · 2014: 20 · 2013: 28 · 2012: 33
- FWCI
- 16.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R33CA097502, R33 CA97502)
- National Institute of General Medical Sciences (R01GM063090, R01 GM 63090)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- alternative splicing, proteome diversity, cystic fibrosis, aberrant splicing, cis-regulatory elements, trans-acting splicing factors, cyclooxygenase-1, paracetamol, cryptic exons, modified oligonucleotides, splicing correction, molecular therapy
- MeSH terms
- Base Sequence, Humans, Phenotype, RNA, Therapeutics, Alternative Splicing, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.